Trial Outcomes & Findings for Purple Grape Juice in Improving Vascular Health in Childhood Cancer Survivors (NCT NCT01043939)

NCT ID: NCT01043939

Last Updated: 2014-12-31

Results Overview

Difference of least square means (95% Confidence Interval) in RH-PAT Index Scores between juice groups. Higher RH-PAT scores indicate better endothelial function; a positive difference of least square means is suggestive of an improvement in endothelial function. Probes were placed on the index fingers of both hands and a blood pressure cuff was placed on one arm. The cuff was inflated to suprasystolic pressure and the digital pulse volume was recorded before, during \& after a 5 minute occlusion period. The ratio of the hyperemic and the baseline pulse amplitude (corrected for the same ratio on the control finger) was calculated and expressed as the RH-PAT index score. Lower scores reflect worse endothelial function.

Recruitment status

COMPLETED

Study phase

PHASE1

Target enrollment

24 participants

Primary outcome timeframe

4 weeks (change since baseline)

Results posted on

2014-12-31

Participant Flow

Participants were recruited from the Metabolic Syndrome Study in Childhood Cancer Survivors and the Long-Term Follow-up Clinic, both at the University of Minnesota, Minneapolis, MN between October 2009 and May 2010.

30 recruited; 6 drop-outs during 4 week run-in period, prior to randomization due to now-show for first clinic visit or concerns regarding time, compliance, or blood draws.

Participant milestones

Participant milestones
Measure
Arm 1 Purple Grape Juice Then Apple Juice
Arm 1: 6 ounces of grape juice twice daily during first 4 weeks of intervention (intervention period 1) followed by a 4 week washout period followed by 6 ounces of clear apple juice twice daily during 4 weeks (intervention period 2).
Arm 2 Apple Juice Then Purple Grape Juice
Arm 2: 6 ounces of clear apple juice twice daily during first 4 weeks of intervention (intervention period 1) followed by a 4 week washout period followed by 6 ounces of purple grape juice twice daily during 4 weeks (intervention period 2).
First Intervention
STARTED
12
12
First Intervention
COMPLETED
12
12
First Intervention
NOT COMPLETED
0
0
Washout Period
STARTED
12
12
Washout Period
COMPLETED
12
12
Washout Period
NOT COMPLETED
0
0
Second Intervention
STARTED
12
12
Second Intervention
COMPLETED
12
12
Second Intervention
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Purple Grape Juice in Improving Vascular Health in Childhood Cancer Survivors

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Entire Study Population
n=24 Participants
Includes groups randomized to receive purple grape juice first and apple juice first
Age, Categorical
<=18 years
19 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
5 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Age, Continuous
15.8 years
STANDARD_DEVIATION 2.6 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
Sex: Female, Male
Male
17 Participants
n=5 Participants
Region of Enrollment
United States
24 participants
n=5 Participants
Weight
60 kilograms
STANDARD_DEVIATION 13.8 • n=5 Participants
Height
165 Centimeters
STANDARD_DEVIATION 11.6 • n=5 Participants
Body Mass Index
22 kg/m^2
STANDARD_DEVIATION 3.2 • n=5 Participants
Systolic blood pressure
111 mmHg
STANDARD_DEVIATION 9.6 • n=5 Participants
Diastolic blood pressure
59 mmHg
STANDARD_DEVIATION 8.3 • n=5 Participants
Fasting glucose
78 mg/dL
STANDARD_DEVIATION 7.0 • n=5 Participants
Fasting insulin
6.3 mU/L
STANDARD_DEVIATION 4.7 • n=5 Participants
Low-density lipoprotein (LDL) Cholesterol
95 mg/dL
STANDARD_DEVIATION 20.1 • n=5 Participants
High-density lipoprotein (HDL) Cholesterol
50 mg/dL
STANDARD_DEVIATION 10.9 • n=5 Participants
Triglycerides
78 mg/dL
STANDARD_DEVIATION 33.7 • n=5 Participants

PRIMARY outcome

Timeframe: 4 weeks (change since baseline)

Population: Intent-to-Treat analysis

Difference of least square means (95% Confidence Interval) in RH-PAT Index Scores between juice groups. Higher RH-PAT scores indicate better endothelial function; a positive difference of least square means is suggestive of an improvement in endothelial function. Probes were placed on the index fingers of both hands and a blood pressure cuff was placed on one arm. The cuff was inflated to suprasystolic pressure and the digital pulse volume was recorded before, during \& after a 5 minute occlusion period. The ratio of the hyperemic and the baseline pulse amplitude (corrected for the same ratio on the control finger) was calculated and expressed as the RH-PAT index score. Lower scores reflect worse endothelial function.

Outcome measures

Outcome measures
Measure
Purple Grape Juice
n=24 Participants
6 ounces of grape juice consumed twice daily in either the first or second intervention period
Apple Juice
n=24 Participants
6 ounces of clear apple juice consumed twice daily in either the first or second intervention period
Change in Endothelial Function (Reactive Hyperemia Peripheral Arterial Tonometry (RH-PAT) Index Score)
0.06 units on a scale
Standard Error 0.089 • Interval -0.42 to 0.11
0.22 units on a scale
Standard Error 0.093 • Interval -0.42 to 0.22

SECONDARY outcome

Timeframe: 4 weeks

Change from baseline in Oxidized LDL at 4 weeks, a biomarker of oxidative stress

Outcome measures

Outcome measures
Measure
Purple Grape Juice
n=24 Participants
6 ounces of grape juice consumed twice daily in either the first or second intervention period
Apple Juice
n=24 Participants
6 ounces of clear apple juice consumed twice daily in either the first or second intervention period
Change in Oxidized LDL
4.66 Units/Liter
Standard Error 2.02
1.57 Units/Liter
Standard Error 2.03

SECONDARY outcome

Timeframe: 4 weeks

Change from baseline in Myeloperoxidase (MPO) at 4 weeks, a biomarker of oxidative stress

Outcome measures

Outcome measures
Measure
Purple Grape Juice
n=24 Participants
6 ounces of grape juice consumed twice daily in either the first or second intervention period
Apple Juice
n=24 Participants
6 ounces of clear apple juice consumed twice daily in either the first or second intervention period
Change in Myeloperoxidase (MPO)
0.95 ng/mL
Interval 0.78 to 1.16
1.03 ng/mL
Interval 0.84 to 1.26

SECONDARY outcome

Timeframe: 4 weeks

Change from baseline in high sensitivity C-Reactive Protein (hs-CRP) at 4 weeks, a biomarker of inflammation

Outcome measures

Outcome measures
Measure
Purple Grape Juice
n=24 Participants
6 ounces of grape juice consumed twice daily in either the first or second intervention period
Apple Juice
n=24 Participants
6 ounces of clear apple juice consumed twice daily in either the first or second intervention period
Change in High Sensitivity C-Reactive Protein (Hs-CRP)
1.42 mg/L
Interval 0.84 to 2.41
1.06 mg/L
Interval 0.62 to 1.8

Adverse Events

Purple Grape Juice

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Apple Juice

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Cindy K. Blair, MPH

Masonic Cancer Center, University of Minnesota

Phone: 612-624-9668

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place